The importance of early-stage blood pressure control in thyroid cancer patients treated with lenvatinib from the perspective of dose intensity.
| Publicado en: | Supportive Care in Cancer Vol. 31; no. 12; pp. 1 - 10 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=173904534&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 173904534 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09414355 O1J jtl: Supportive Care in Cancer issn: 09414355 maglogo: N pubinfo: dt: Dec2023 vid: 31 iid: 12 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 173904534 10.1007/s00520-023-08163-x 173904534 ppf: 1 ppct: 9 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: The importance of early-stage blood pressure control in thyroid cancer patients treated with lenvatinib from the perspective of dose intensity. aug: au: Masaki, Chie Shioya, Junko Sugino, Kiminori Terasawa, Yukiko Yokotsuka, Satoshi Nakata, Misako Kitagawa, Wataru Ito, Koichi affil: Department of Surgery, Ito Hospital, 4-3-6 Jingumae, 150-8308, Shibuya-ku, Tokyo, Japan sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|